Congress reprises FDA heparin probe; Big pharma lobbies for tougher theft penalties;

> House Republican Fred Upton wants the FDA's documentation from its probe of the 2008 incident of contaminated heparin from China: "There is reason to believe all or some of the individuals responsible for the adulteration are still actively engaged in the Chinese pharmaceutical supply chain." Story

> Abbott Labs, GlaxoSmithKline, J&J and Novo Nordisk have formed a coalition to push for tougher penalties for drug theft. Article

> Purdue Pharma's RxPATROL collaboration has donated $2,500 to the group Silent Witness, increasing the reward for information on a Phoenix heist of 6,200 OxyContin pills. Story

> The Royal Pharmaceutical Society finds Scotland's supply chain "brittle." Story

> Swiss API maker Carbogen Amcis is eliminating 60 of its 350 positions due to restructuring. Carbogen Amcis release

> Pristine Pharma Corp has begun operations at its new Massena, NY-based manufacturing plant  following FDA registration. Pristine release

> The Armenian pharmaceutical industry will apply GMP standards by 2013 to increase drug exports. Story

> Contract manufacturer ScinoPharm has contracted with Clinical Data and will produce vilazodone hydrochloride, the API for the latter's newly approved depression treatment, Viibryd. Story